References
- Akinosoglou K, Schinas G, Gogos C. 2022. Oral antiviral treatment for COVID-19: a comprehensive review on nirmatrelvir/ritonavir. Viruses 14(11):2540.
- Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H. 2020. Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. J Prev Med Hyg 61(3):E304.
- Aljaberi MA, Al-Sharafi MA, Uzir MUH, Sabah A, Ali AM, Lee K-H, Alsalahi A, Noman S, Lin C-Y. 2023. Psychological toll of the COVID-19 pandemic: an in-depth exploration of anxiety, depression, and insomnia and the influence of quarantine measures on daily life. Healthcare 11:2418.
- Altindis M, Puca E, Shapo L. 2022. Diagnosis of monkeypox virus: an overview. Travel Med Infect Dis 50:102459.
- Andrei G, Snoeck R. 2023. Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development. Trends Pharmacol Sci 44(10):719–739.
- Bagcchi S. 2020. Stigma during the COVID-19 pandemic. Lancet Infect Dis 20(7):782.
- Behera JK, Mishra P, Jena AK, Behera B, Bhattacharya M. 2023. Human health implications of emerging diseases and the current situation in India’s vaccine industry. Sci One Health 1:100046.
- Bhola S, Trisal J, Thakur V, Kaur P, Kulshrestha S, Bhatia SK, Kumar P. 2022. Neurological toll of COVID-19. Neurol Sci 43(4):2171–2186.
- Bloch EM, Sullivan DJ, Shoham S, Tobian AAR, Casadevall A, Gebo KA. 2022. The potential role of passive antibody-based therapies as treatments for monkeypox. mBio 13(6):e02862-22.
- Bryer J, Freeman EE, Rosenbach M. 2022. Monkeypox emerges on a global scale: a historical review and dermatologic primer. J Am Acad Dermatol 87(5):1069–1074.
- Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R. 2022. The changing epidemiology of human monkeypox: a systematic review. PLoS Negl Trop Dis 16(2):e0010141.
- Caceres MMF, Sosa JP, Lawrence JA, Sestacovschi C, Tidd-Johnson A, Rasool MHU, Gadamidi VK, Ozair S, Pandav K, Cuevas-Lou C. 2022. The impact of misinformation on the COVID-19 pandemic. AIMS Public Health 9(2):262.
- Caria J, Pinto R, Leal E, Almeida V, Cristóvão G, Gonçalves AC, Torres M, Santos MB, Pinheiro H, Póvoas D. 2022. Clinical and epidemiological features of hospitalized and ambulatory patients with human monkeypox infection: a retrospective observational study in Portugal. Infect Dis Rep 14(6):810–823.
- Centers for Disease Control and Prevention. 2025. Mpox: 2022 global outbreak – situation summary. Available from: https://www.cdc.gov/poxvirus/mpox/
- Cevik M, Kuppalli K, Kindrachuk J, Peiris M. 2020. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ 371:m3862.
- Chakraborty C, Bhattacharya M, Sharma AR, Dhama K. 2022. Evolution, epidemiology, geographical distribution, and mutational landscape of newly emerging monkeypox virus. Geroscience 44(6):2895–2911.
- Chen J, Wang R, Wang M, Wei G-W. 2020. Mutations strengthened SARS-CoV-2 infectivity. J Mol Biol 432(19):5212–5226.
- Chenchula S, Atal S, Ghanta MK, Uppugunduri CR, Karunakaran S, Amerneni KC, Sarma P, Prakash S, Amerneni LS, Padmavathi R. 2025. Emerging variants of mpox virus and tecovirimat resistance: genomic insights and implications for treatment strategies. Virology 608:110532.
- Delamonica B, Davalos L, Larijani M, Anthony SJ, Liu J, Mac-Carthy T. 2023. Evolutionary potential of the monkeypox genome arising from interactions with human APOBEC3 enzymes. Virus Evol 9(2):vead047.
- Desingu PA, Rubeni T, Sundaresan NR. 2022. Evolution of monkeypox virus from 2017 to 2022 in light of point mutations. Front Microbiol 13:1037598.
- Domingo E, García-Crespo C, Lobo-Vega R, Perales C. 2021. Mutation rates, mutation frequencies, and proofreading–repair activities in RNA virus genetics. Viruses 13(9):1882.
- Duchoslav V, Boura E. 2023. Structure of monkeypox virus poxin: implications for drug design. Arch Virol 168(7):192.
- Edet U, Clement M, Mkpuma N, Ehiakhamen O, Umar Y, Shittu I, Adedeji A. 2023. Emergence and diversity of monkeypox virus clade IIb sub-lineages in Nigeria (1971–2023) and its role in the 2022 global outbreak. SSRN Preprint. Available from: https://ssrn.com/abstract=5293482.
- Elsayed S, Bondy L, Hanage WP. 2022. Monkeypox virus infections in humans. Clin Microbiol Rev 35(4):e00092-22.
- Esmaeilzadeh A, Ebrahimi F, Jahani Maleki A, Siahmansouri A. 2024. EG.5 (Eris) and BA.2.86 (Pirola) subvariants of SARS-CoV-2: a new face of old COVID-19. Infection 52(2):337–343.
- Feng Z, Huang J, Baboo S, Diedrich JK, Bangaru S, Paulson JC, Yates JR, Yuan M, Wilson IA, Ward AB. 2025. Structural and functional insights into the evolution of SARS-CoV-2 KP.3.1.1 spike protein. Cell Rep 44(7):113201.
- Fernandes Q, Inchakalody VP, Merhi M, Mestiri S, Taib N, Moustafa Abo El-Ella D, Bedhiafi T, Raza A, Al-Zaidan L, Mohsen MO. 2022. Emerging COVID-19 variants and their impact on diagnosis, therapeutics, and vaccines. Ann Med 54(1):524–540.
- Forni D, Molteni C, Cagliani R, Sironi M. 2023. Geographic structuring and divergence time frame of monkeypox virus in the endemic region. J Infect Dis 227(6):742–751.
- Gaba A, Flath B, Chelico L. 2021. Examination of the APOBEC3 barrier to cross-species transmission of primate lentiviruses. Viruses 13(6):1084.
- Gong Q, Wang C, Chuai X, Chiu S. 2022. Monkeypox virus: a re-emergent threat to humans. Virol Sin 37(4):477–482.
- Hasan S, Saeed S. 2022. Monkeypox disease: an emerging public health concern in the shadow of the COVID-19 pandemic. Trop Med Infect Dis 7(10):283.
- Hashemian SMR, Sheida A, Taghizadieh M, Memar MY, Hamblin MR, Baghi HB, Nahand JS, Asemi Z, Mirzaei H. 2023. Paxlovid (nirmatrelvir/ritonavir): a new approach to COVID-19 therapy. Biomed Pharmacother 162:114367.
- Isidro J, Borges V, Pinto M, Sobral D, Santos JD, Nunes A, Mixão V, Ferreira R, Santos D, Duarte S. 2022. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat Med 28(8):1569–1572.
- Islam A, Pakrashi D, Vlassopoulos M, Wang LC. 2021. Stigma and misconceptions during COVID-19: a field experiment in India. Soc Sci Med 278:113966.
- Jain N, Umar TP, Sayad R, Mokresh ME, Tandarto K, Siburian R, Liana P, Laivacuma S, Reinis A. 2024. Monkeypox diagnosis in clinical settings: a comprehensive review of best laboratory practices. In: Poxviruses. p. 253–271.
- Jakobsdottir GM, Brewer DS, Cooper C, Green C, Wedge DC. 2022. APOBEC3 mutational signatures are associated with genomic instability across tumour types. BMC Biol 20:117.
- Jesse O, Obohwemu KO. 2024. The growing prevalence of mpox and the impact on mental health. Am J Soc Sci Educ Innov 6(11):129–133.
- Kaler J, Hussain A, Flores G, Kheiri S, Desrosiers D. 2022. Monkeypox: a comprehensive review of transmission, pathogenesis and clinical features. Cureus 14(7):e26756.
- Kannan SR, Spratt AN, Cohen AR, Naqvi SH, Chand HS, Quinn TP, Lorson CL, Byrareddy SN, Singh K. 2021. Evolutionary analysis of the Delta and Delta Plus variants of SARS-CoV-2. J Autoimmun 124:102715.
- Karagoz A, Tombuloglu H, Alsaeed M, Tombuloglu G, Al-Rubaish AA, Mahmoud A, Smajlović S, Ćordić S, Rabaan AA, Alsuhaimi E. 2023. Monkeypox virus: classification, origin, transmission, genome organization, antiviral drugs, and diagnosis. J Infect Public Health 16(4):531–541.
- Khailany RA, Safdar M, Ozaslan M. 2020. Genomic characterization of a novel SARS-CoV-2. Gene Rep 19:100682.
- Kugelman JR, Johnston SC, Mulembakani PM, Kisalu N, Lee MS, Koroleva G, McCarthy SE, Gestole MC, Wolfe ND, Fair JN. 2014. Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo. Emerg Infect Dis 20(2):232–232.
- Kumar R, Nagar S, Haider S, Sood U, Ponnusamy K, Dhingra GG, Anand S, Dua A, Singh M, Sengar M. 2022. Monkeypox virus phylogenomics and host–pathogen interactions. bioRxiv. 2022.07.25.501367.
- Li P, Li J, Ayada I, Avan A, Zheng Q, Peppelenbosch MP, de Vries AC, Pan Q. 2023. Clinical features, antiviral treatment, and patient outcomes in the 2022 mpox outbreak. J Infect Dis 228(4):391–401.
- Liu J, Wang X, Wang Z, Chen S. 2025. Psychological crisis and emergency response in public health emergencies: a case study of the mpox epidemic. BMC Psychol 13:956.
- Lu Y, Ao D, He X, Wei X. 2024. The rising SARS-CoV-2 JN.1 variant: evolution, infectivity, immune escape, and response strategies. MedComm 5(8):e675.
- Maronese CA, Avallone G, Aromolo IF, Spigariolo CB, Quattri E, Ramoni S, Carrera CG, Marzano AV. 2023. Mpox: an updated review of dermatological manifestations. Br J Dermatol 189(3):260–270.
- Martínez-Fernández DE, Fernández-Quezada D, Casillas-Muñoz FAG, Carrillo-Ballesteros FJ, Ortega-Prieto AM, Jimenez-Guardeño JM, Regla-Nava JA. 2023. Human monkeypox: an overview of epidemiology, pathogenesis, diagnosis, treatment, and prevention. Pathogens 12(7):947.
- McFarland SE, Marcus U, Hemmers L, Miura F, Martínez JI, Martínez FM, Montalbán EG, Chazelle E, Mailles A, Silue Y. 2023. Estimated mpox incubation period distributions among festival-associated cases. Euro Surveill 28(27):2200806.
- Musuka G, Moyo E, Tungwarara N, Mhango M, Pierre G, Saramba E, Iradukunda PG, Dzinamarira T. 2024. Mpox outbreaks, risk factors, and prevention efforts in Africa. IJID Reg 1:100402.
- Nakazawa Y, Mauldin MR, Emerson GL, Reynolds MG, Lash RR, Gao J, Zhao H, Li Y, Muyembe J-J, Mbala Kingebeni P. 2015. A phylogeographic investigation of African monkeypox. Viruses 7(4):2168–2184.
- Nerlich B, Jaspal R. 2025. Mpox in the news: social representations, identity, stigma and coping. Med Humanit 51(1):161–171.
- Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, Hou C, Wang H, Liu J, Yang D. 2020. Role of ACE2 in COVID-19. Crit Care 24:1–10.
- O’Toole Á, Neher RA, Ndodo N, Borges V, Gannon B, Gomes JP, Groves N, King DJ, Maloney D, Lemey P. 2023. APOBEC3 editing in mpox virus suggests sustained human transmission since 2016. Science 382(6670):595–600.
- Okwor T, Mbala PK, Evans DH, Kindrachuk J. 2023. Clade-specific virological differences in monkeypox viruses. Clin Microbiol Infect 29(12):1502–1507.
- Orsini D, Sartini M, Spagnolo AM, Cristina ML, Martini M. 2024. Mpox stigma: historical, social, and ethical issues. J Prev Med Hyg 64(4):E398.
- Otieno JR, Ruis C, Onoja AB, Kuppalli K, Hoxha A, Nitsche A, Brinkmann A, Michel J, Mbala-Kingebeni P, Mukadi-Bamuleka D. 2025. Global genomic surveillance of monkeypox virus. Nat Med 31(1):342–350.
- Pachetti M, Marini B, Benedetti F, Giudici F, Mauro E, Storici P, Masciovecchio C, Angeletti S, Ciccozzi M, Gallo RC. 2020. SARS-CoV-2 mutation hot spots and a novel RdRp variant. J Transl Med 18:1–9.
- Papukashvili D, Rcheulishvili N, Liu C, Wang X, He Y, Wang PG. 2022. Nucleic acid-based universal monkeypox vaccine candidates. Front Immunol 13:1050309.
- Patel KP, Vunnam SR, Patel PA, Krill KL, Korbitz PM, Gallagher JP, Suh JE, Vunnam RR. 2020. Transmission of SARS-CoV-2: an update. Eur J Clin Microbiol Infect Dis 39:2005–2011.
- Poland GA, Kennedy RB, Tosh PK. 2022. Prevention of monkeypox with vaccines: a rapid review. Lancet Infect Dis 22(12):e349–e358.
- Ranga U. 2021. SARS-CoV-2 aerosol and droplets: an overview. Virusdisease 32(2):190–197.
- Rani I, Joshi H, Sharma U, Kaur J, Sood S, Ramniwas S, Chauhan A, Abdulabbas HS, Tuli HS. 2024. Potential use of cidofovir, brincidofovir, and tecovirimat in fighting monkeypox infection. Naunyn Schmiedebergs Arch Pharmacol 397(4):2055–2065.
- Realegeno S, Puschnik AS, Kumar A, Goldsmith C, Burgado J, Sambhara S, Olson VA, Carroll D, Damon I, Hirata T. 2017. Monkeypox virus host factor screen identifies essential role of GARP complex. J Virol 91(11):e00011-17.
- Riou C, Keeton R, Moyo-Gwete T, Hermanus T, Kgagudi P, Baguma R, Valley-Omar Z, Smith M, Tegally H, Doolabh D. 2021. Escape of SARS-CoV-2 variants from T-cell recognition. Sci Transl Med 14(631):eabj6824.
- Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y. 2022. Prevention and treatment of monkeypox. Drugs 82(9):957–963.
- Sah R, Abdelaal A, Reda A, Katamesh BE, Manirambona E, Abdelmonem H, Mehta R, Rabaan AA, Alhumaid S, Alfouzan WA. 2022. Monkeypox and possible sexual transmission. Pathogens 11(8):924.
- Satheshkumar PS, Gigante CM, Mbala-Kingebeni P, Nakazawa Y, Anderson M, Balinandi S, Mulei S, Fuller J, McQuiston JH, McCollum AM. 2025. Emergence of clade Ib monkeypox virus: current evidence. Emerg Infect Dis 31(8):1516.
- Shchelkunova GA, Shchelkunov SN. 2022. Smallpox, monkeypox, and other human orthopoxvirus infections. Viruses 15(1):103.
- Shiraz R, Tripathi S. 2023. Enhanced recombination among Omicron subvariants contributes to viral immune escape. J Med Virol 95(2):e28519.
- Simpson K, Heymann D, Brown CS, Edmunds WJ, Elsgaard J, Fine P, Hochrein H, Hoff NA, Green A, Ihekweazu C. 2020. Human monkeypox: an unintended consequence of smallpox eradication. Vaccine 38(33):5077–5081.
- Singhal T, Kabra S, Lodha R. 2022. Monkeypox: a review. Indian J Pediatr 89(10):955–960.
- Smith AK, Storer D, Lancaster K, Haire B, Newman CE, Paparini S, MacGibbon J, Cornelisse VJ, Broady TR, Lockwood T. 2024. Mpox illness narratives: stigma and recovery. Qual Health Res 34(12):1161–1174.
- Smith TG, Gigante CM, Wynn NT, Matheny A, Davidson W, Yang Y, Condori RE, O’Connell K, Kovar L, Williams TL. 2023. Resistance to tecovirimat during the 2022 mpox outbreak in the US. medRxiv. 2023.05.16.23289856.
- Stefano JS, e Silva LRG, Kalinke C, de Oliveira PR, Crapnell RD, Brazaca LC, Bonacin JA, Campuzano S, Banks CE, Janegitz BC. 2023. Human monkeypox virus: detection methods and perspectives. TrAC Trends Anal Chem 167:117226.
- Sultana A, Sultana A, Shawon NJ, Kabir S, Chowdhury AA, Amran MS. 2024. Monkeypox: in quest of effective vaccines. Indo Global J Pharm Sci 14:11–24.
- Taha AM, Mahmoud AM, Abouelmagd K, Saed SAA, Khalefa BB, Shah S, Satapathy P, Shamim MA, Sah S, Serhan HA. 2024. Effectiveness of a single dose of JYNNEOS vaccine: a systematic review and meta-analysis. Health Sci Rep 7(9):e70069.
- Telenti A, Hodcroft EB, Robertson DL. 2022. The evolution and biology of SARS-CoV-2 variants. Cold Spring Harb Perspect Med 12(5):a041390.
- Trilla A, Trilla G, Aldea M, Vilella A. 2025. What is next for COVID-19 vaccination? In: Semin Respir Crit Care Med. Thieme Medical Publishers.
- Vasconcellos-Silva PR, Castiel LD. 2020. COVID-19, fake news, and communicative risk narratives. Cad Saude Publica 36:e00101920.
- Velavan TP, Meyer CG. 2022. Monkeypox 2022 outbreak: an update. Trop Med Int Health 27(7):604–605.
- Venkatesan P. 2022. Monkeypox transmission: what we know so far. Lancet Respir Med 10(11):e101.
- Verma RK, Gangwar A. 2024. Characterization of fowlpox virus. In: Poxviruses. p. 55–74.
- Vitiello A, Ferrara F, Auti AM, Di Domenico M, Boccellino M. 2022. Advances in Omicron variant development. J Intern Med 292(1):81–90.